1. Home
  2. Directory
  3. Pennsylvania
  4. Scranton
  5. Physician Assistant
  6. NPI Profile
  7. Prescriptions 1306567201

MARIA KATHERINE DELEO PA-C
Prescription History 1306567201
Physician Assistant in Scranton, PA

NPI Status: Active since September 08, 2022

Contact Information

531 MT PLEASANT DR
SCRANTON, PA
ZIP 18503
Phone: (570) 575-4926
Fax: (570) 558-2290

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MARIA KATHERINE DELEO PA-C, an active Physician Assistant specialist practicing in Scranton, PA. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 109 documented patient claims. Among these therapy options, the most frequently utilized medication is Ozempic, which accounts for 73 claims alone.

Medication Index

B
N
O
No matching medications currently found on file.

Bupropion Hcl Sr

Generic Formulation: Bupropion HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 19
30-Day Fills 23.0
Days Supply 690
PA State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills50.1
Peer Average Days Supply1,457
Conservative Utilization

This provider writes prescriptions for this formulation 38.7% less frequently than the standard regional baseline metric for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $323.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.04

State Avg Cost Per Claim

$30.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Naltrexone Hcl

Generic Formulation: Naltrexone HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 17
30-Day Fills 27.1
Days Supply 814
PA State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills24.1
Peer Average Days Supply673
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $676.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.81

State Avg Cost Per Claim

$50.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to prevent people who have been addicted to certain drugs (opiates) from taking them again. It is used as part of a complete treatment program for drug abuse (such as compliance monitoring, counseling, behavioral contract, lifestyle changes). This medication must not be used in people currently taking opiates, including methadone. Doing so can cause sudden withdrawal symptoms. Naltrexone belongs to a class of drugs known as opiate antagonists. It works in the brain to prevent opiate effects (such as feelings of well-being, pain relief). It also decreases the desire to take opiates. Ask your doctor or pharmacist if you should have naloxone available to treat opioid overdose. Teach your family or household members about the signs of an opioid overdose and how to treat it. This medication is also used to treat alcohol abuse. It can help people drink less alcohol or stop drinking altogether. It also decreases the desire to drink alcohol when used with a treatment program that includes counseling, support, and lifestyle changes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 73
30-Day Fills 100.5
Days Supply 2,916
PA State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills63.6
Peer Average Days Supply1,851
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 65.9% higher than the standard regional baseline profile for PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $92,642.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,269.08

State Avg Cost Per Claim

$1,290.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MARIA KATHERINE DELEO PA-C provides transparency into local medical care patterns within Scranton, PA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physician Assistant** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.